Clinical trial
Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting (The SHARP-P Study)
NCT03740906 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting (The SHARP-P Study)
- Lead sponsor
- Kirby Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 6, 2019
- Completion date
- March 31, 2022
- Enrollment
- 202 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.